Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis

MLA

Henrik Jessen, et al. “Longitudinal Serological Assessment of Type VI Collagen Turnover Is Related to Progression in a Real-World Cohort of Idiopathic Pulmonary Fibrosis.” BMC Pulmonary Medicine, vol. 21, no. 1, Nov. 2021, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s12890-021-01684-3.

APA

Henrik Jessen, Nils Hoyer, Thomas S. Prior, Peder Frederiksen, Sarah R. Rønnow, Morten A. Karsdal, Diana J. Leeming, Elisabeth Bendstrup, Jannie M. B. Sand, & Saher B. Shaker. (2021). Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis. BMC Pulmonary Medicine, 21(1), 1–8. https://doi.org/10.1186/s12890-021-01684-3

Chicago

Henrik Jessen, Nils Hoyer, Thomas S. Prior, Peder Frederiksen, Sarah R. Rønnow, Morten A. Karsdal, Diana J. Leeming, Elisabeth Bendstrup, Jannie M. B. Sand, and Saher B. Shaker. 2021. “Longitudinal Serological Assessment of Type VI Collagen Turnover Is Related to Progression in a Real-World Cohort of Idiopathic Pulmonary Fibrosis.” BMC Pulmonary Medicine 21 (1): 1–8. doi:10.1186/s12890-021-01684-3.